GlassScriptPhysician profile
Rasiq Zackria
NPI 1902347289
$20,293.91
in general payments reported to CMS, 2019-2025
16 companies · $9,541 in 2025
The $9,541 reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.23 · 2021: $260 · 2022: $322 · 2023: $1,030 · 2024: $9,117 · 2025: $9,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $13K · Travel and Lodging: $4,534 · Food and Beverage: $2,654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $12,500.00 |
| Travel and Lodging | $4,534.16 |
| Food and Beverage | $2,654.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16,932.30 | 2021-2025 | General - Therapies, Axios, Overstitch Endoscopic Suturing System |
| Olympus Corporation of The Americas | $1,484.30 | 2024-2025 | Olympus, Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655 |
| Ovesco Endoscopy USA, INC. | $573.19 | 2025 | |
| Abbvie INC. | $332.83 | 2021-2023 | Skyrizi, Rinvoq |
| Gilead Sciences, INC. | $223.94 | 2023-2024 | Epclusa |
| Mallinckrodt Hospital Products INC. | $132.69 | 2023 | Terlivaz |
| Janssen Scientific Affairs, LLC | $122.20 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $121.81 | 2023 | |
| Pfizer INC. | $84.70 | 2022 | |
| Lilly USA, LLC | $84.10 | 2023 | |
| Merit Medical Systems INC | $75.94 | 2024 | Esophyx |
| Conmed Corporation | $34.25 | 2023 | Conmed Biliary, Conmed Generators |
| Takeda Pharmaceuticals U.S.A., INC. | $33.88 | 2023-2024 | Entyvio |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.23 | 2020 | |
| Janssen Biotech, INC. | $17.74 | 2024 | Stelara |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $16.81 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rasiq Zackria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.